“Previous technologies delivered energy through the epidermis to the papillary dermis to cause the denaturation and contraction of collagen. We’ve pretty much exhausted surface applied technologies, so [evolastin] takes us to the next level.
Over the years we’ve discovered that laxity is an issue in itself, separate from wrinkling and other aspects of skin aging. There are a great many genetic conditions and mutations involved, and the majority of them appear to be in the genes that deal with elastin. This gives us a strong rationale that any device stimulating elastinogenesis will be much more effective than a modality promoting neocollagenesis alone. I believe [evolastin] is so effective for laxity reduction because it promotes both.”
Macrene Alexiades-Armenakas, M.D., Ph.D., F.A.A.D. – New York, NY